
Collegium Pharmaceutical Inc
NASDAQ:COLL

Intrinsic Value
The intrinsic value of one
COLL
stock under the Base Case scenario is
60.43
USD.
Compared to the current market price of 28.82 USD,
Collegium Pharmaceutical Inc
is
Undervalued by 52%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Collegium Pharmaceutical Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Collegium Pharmaceutical Inc
Balance Sheet Decomposition
Collegium Pharmaceutical Inc
Current Assets | 527.6m |
Cash & Short-Term Investments | 197.8m |
Receivables | 228.7m |
Other Current Assets | 101.1m |
Non-Current Assets | 1.1B |
PP&E | 19.4m |
Intangibles | 986.7m |
Other Non-Current Assets | 97.8m |
Free Cash Flow Analysis
Collegium Pharmaceutical Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Collegium Pharmaceutical Inc
Revenue
|
664.3m
USD
|
Cost of Revenue
|
-281.1m
USD
|
Gross Profit
|
383.2m
USD
|
Operating Expenses
|
-252.4m
USD
|
Operating Income
|
130.8m
USD
|
Other Expenses
|
-86.9m
USD
|
Net Income
|
43.9m
USD
|
COLL Profitability Score
Profitability Due Diligence
Collegium Pharmaceutical Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Score
Collegium Pharmaceutical Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
COLL Solvency Score
Solvency Due Diligence
Collegium Pharmaceutical Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Score
Collegium Pharmaceutical Inc's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
COLL Price Targets Summary
Collegium Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for
COLL
is 43.66 USD
with a low forecast of 36.36 USD and a high forecast of 52.5 USD.
Dividends
Current shareholder yield for COLL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
COLL
stock under the Base Case scenario is
60.43
USD.
Compared to the current market price of 28.82 USD,
Collegium Pharmaceutical Inc
is
Undervalued by 52%.